Scorpius Holdings, Inc. (SCPX)
OTCMKTS · Delayed Price · Currency is USD
0.0110
+0.0090 (450.00%)
Aug 8, 2025, 3:43 PM EDT

Scorpius Holdings Company Description

Scorpius Holdings, Inc., through its subsidiary Scorpius BioManufacturing, operates as an integrated contract development and manufacturing organization.

The company engages in clinical and commercial drug substance manufacturing; and release and stability testing activities.

It is also involved in the provision of various process development services, including upstream and downstream development and optimization, and analytical method development solutions, as well as cell line development, testing, and characterization services.

The company serves the biotechnology and biopharmaceutical industries. The company was formerly known as NightHawk Biosciences, Inc. and changed its name to Scorpius Holdings, Inc. in February 2024.

Scorpius Holdings, Inc. was incorporated in 2008 and is based in San Antonio, Texas.

Scorpius Holdings, Inc.
CountryUnited States
Founded2008
IndustryBiotechnology
SectorHealthcare
Employees91
CEOJeffrey Wolf

Contact Details

Address:
1305 East Houston Street
San Antonio, Delaware 78205
United States
Phone919 240 7133
Websitescorpiusbiologics.com

Stock Details

Ticker SymbolSCPX
ExchangeOTCMKTS
Stock TypeCommon Stock
Fiscal YearJanuary - December
Reporting CurrencyUSD
ISIN NumberUS42237K4094
SIC Code2836

Key Executives

NamePosition
Jeffrey Alan Wolf J.D.Founder, Chairman, President and Chief Executive Officer
William L. OstranderChief Financial Officer, Principal Accounting Officer, Controller and Secretary
Dr. Justin Stebbing FRCP, FRCPath, M.A., M.D., Ph.D.Chief Medical Advisor and Member of Scientific and Clinical Advisory Board
Colonel George E. Peoples Jr., F.A.C.S., M.D.Chief Medical Advisor
Joe PaynePresident and Chief Operating Officer of Scorpius BioManufacturing
Nicole TempleSenior Manager and Head of Program Management